CD22 CAR T-cell therapy: new hope for patients with large B-cell lymphoma

Lancet. 2024 Jul 27;404(10450):314-315. doi: 10.1016/S0140-6736(24)00815-8. Epub 2024 Jul 9.

Authors

Maria-Luisa Schubert¹, Peter Dreger²

Affiliations

¹ Department Medicine V, University of Heidelberg, Heidelberg 69120, Germany.
² Department Medicine V, University of Heidelberg, Heidelberg 69120, Germany. Electronic address: [email protected].

PMID: 38996464
DOI: 10.1016/S0140-6736(24)00815-8

No abstract available

MeSH terms

Humans
Immunotherapy, Adoptive* / methods
Lymphoma, Large B-Cell, Diffuse* / immunology
Lymphoma, Large B-Cell, Diffuse* / therapy
Receptors, Antigen, T-Cell / immunology
Receptors, Chimeric Antigen / immunology
Sialic Acid Binding Ig-like Lectin 2* / immunology

Substances

Sialic Acid Binding Ig-like Lectin 2
CD22 protein, human
Receptors, Chimeric Antigen
Receptors, Antigen, T-Cell